Carna Biosciences, Inc.
4572.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥5 | ¥9 | ¥7 | ¥14 |
| - Cash | ¥2 | ¥3 | ¥3 | ¥4 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥1 |
| Enterprise Value | ¥3 | ¥6 | ¥4 | ¥11 |
| Revenue | ¥1 | ¥2 | ¥1 | ¥2 |
| % Growth | -60.9% | 17.2% | -31.3% | – |
| Gross Profit | ¥0 | ¥1 | ¥1 | ¥2 |
| % Margin | 73.2% | 89.2% | 87.6% | 93.3% |
| EBITDA | -¥2 | -¥1 | -¥1 | -¥1 |
| % Margin | -336.3% | -67.1% | -92.6% | -25.2% |
| Net Income | -¥2 | -¥1 | -¥1 | -¥1 |
| % Margin | -342.4% | -70.9% | -97.3% | -26.5% |
| EPS Diluted | -121.64 | -68.62 | -99.1 | -42.1 |
| % Growth | -77.3% | 30.8% | -135.4% | – |
| Operating Cash Flow | -¥1 | -¥2 | -¥1 | -¥2 |
| Capital Expenditures | -¥0 | -¥0 | -¥0 | -¥0 |
| Free Cash Flow | -¥1 | -¥2 | -¥1 | -¥2 |